APA (7th ed.) Citation

M, T., M, Y., N, I., K, K., & N, H. (2019). Standard antifungal therapy for pulmonary cryptococcosis to improve prognosis - Authors' reply. The Lancet. Infectious diseases, 19(12), 1281. https://doi.org/10.1016/S1473-3099(19)30628-0

Chicago Style (17th ed.) Citation

M, Taniwaki, Yamasaki M, Ishikawa N, Kawamoto K, and Hattori N. "Standard Antifungal Therapy for Pulmonary Cryptococcosis to Improve Prognosis - Authors' Reply." The Lancet. Infectious Diseases 19, no. 12 (2019): 1281. https://doi.org/10.1016/S1473-3099(19)30628-0.

MLA (9th ed.) Citation

M, Taniwaki, et al. "Standard Antifungal Therapy for Pulmonary Cryptococcosis to Improve Prognosis - Authors' Reply." The Lancet. Infectious Diseases, vol. 19, no. 12, 2019, p. 1281, https://doi.org/10.1016/S1473-3099(19)30628-0.